Joseph Mikhael

Philosophy of bioinformatics: extended cognition, analogies and mechanisms

Joseph Mikhael, Joseph Mikhael, 2007 .

Plasma cell leukemia: A review of the molecular classification, diagnosis, and evidenced-based treatment.

J. Keats, Sheri Skerget, K. Gowin, 2021, Leukemia research.

Culturally Responsive Care Delivery in Oncology: The Example of Multiple Myeloma.

Brandon Blue, Joseph Mikhael, Amy E. Pierre, 2023, Clinical lymphoma, myeloma & leukemia.

Chimeric Antigen Receptor T-Cell Therapies: Barriers and Solutions to Access.

N. Shah, Jessica Fowler, Joseph Mikhael, 2022, JCO oncology practice.

Isatuximab, carfilzomib, and dexamethasone in patients with relapsed multiple myeloma: updated results from IKEMA, a randomized Phase 3 study

M. Dimopoulos, R. Hájek, A. Oriol, 2023, Blood cancer journal.

Management of multiple myeloma-related renal impairment: recommendations from the International Myeloma Working Group.

M. Mohty, S. Rajkumar, P. Moreau, 2023, The Lancet. Oncology.

P916: LONG-TERM OUTCOMES WITH ISATUXIMAB-CARFILZOMIB-DEXAMETHASONE (ISA-KD) IN RELAPSED MULTIPLE MYELOMA PATIENTS WITH 1Q21+ STATUS: UPDATED RESULTS FROM THE PHASE 3 IKEMA STUDY

P. Moreau, T. Facon, K. Yong, 2023, HemaSphere.

Carfilzomib, daratumumab, and dexamethasone (KdD) vs. lenalidomide-sparing pomalidomide-containing triplet regimens for relapsed/refractory multiple myeloma: an indirect treatment comparison

Ian McFadden, M. Beksaç, Joseph Mikhael, 2024, Leukemia & lymphoma.